The activity of just a few genes could hold the key to predicting the fate of multiple myeloma patients
Multiple myeloma is a type of cancer affecting the blood plasma cells in bone marrow responsible for producing antibodies. Each year, nearly 14,600 Americans are diagnosed with multiple myeloma. The severity ranges from low-risk to high-risk and makes all the difference in patients' odds of survival.





